Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Pharmadrug Inc (LMLLF)

Pharmadrug Inc (LMLLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine Newsfile - Thu May 23, 7:10AM CDT

Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine Newsfile - Wed May 15, 7:08AM CDT

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization Newsfile - Mon May 13, 7:08AM CDT

Toronto, Ontario--(Newsfile Corp. - May 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug Announces Director Appointment and Resignation Newsfile - Thu May 2, 3:56PM CDT

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine Newsfile - Wed May 1, 7:56AM CDT

Toronto, Ontario--(Newsfile Corp. - May 1, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine Newsfile - Tue Apr 16, 7:52AM CDT

Victoria's Chiral Labs to lead development of novel cocaine manufacturing processToronto, Ontario--(Newsfile Corp. - April 16, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine Newsfile - Wed Mar 13, 6:32AM CDT

Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman Newsfile - Tue Feb 27, 7:06AM CST

Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies Newsfile - Wed Feb 14, 7:34AM CST

Company to pursue regulatory filing for Phase I/II clinical studyToronto, Ontario--(Newsfile Corp. - February 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"),...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers Newsfile - Mon Feb 12, 7:50AM CST

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), today announced that it has entered into (i) a marketing and distribution...

LMLLF : 0.0135 (-12.90%)
PHRX.CN : 0.0200 (unch)

Barchart Exclusives

Unusual Options Activity Supports Rivian (RIVN) But Infrastructure is Key Barchart - Mon Jul 1, 12:00PM CDT
Although RIVN stock is riding high on a major investment deal, the real beneficiary could be the EV infrastructure play. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot